Evaluation of neck masses is frequent in ear, nose, and throat clinics. Successful outcomes associated with neck mass are directly related to rapid diagnosis and accurate treatment for each patient. Late diagnosis of a malignant mass increases the magnitude of morbidity and the rate of mortality of the disease. Although magnetic resonance imaging and computed tomography (CT) examinations are important tools for evaluating head and neck pathologies, they do not allow functional evaluation. For this reason, CT perfusion (CTP) as a method of functional evaluation for distinguishing benign from malignant masses is gaining attention. The utility of CTP for distinguishing between benign and malignant mass lesions was investigated in 35 patients with masses in the neck (11 benign, 24 malignant). CTP was shown to be a useful method for identifying head and neck tumors and blood volume values to enable the differential diagnosis of benign and malignant head and neck tumors.
Introduction
Magnetic resonance imaging (MRI) and computed tomography (CT) are diagnostic methods frequently used for investigating head and neck pathologies.
However, they are not well suited for identifying pathologies of abnormal texture, a limitation that could be eliminated by the development and use of CT perfusion (CTP). The aim of this study was to investigate the utility of CTP for distinguishing benign from malignant mass lesions.
Patients and methods
Thirty-five patients (20 men, 15 women) with masses in the neck were included in the study. The average patient age was 55 years. Histopathologic analysis of the lesions (11 benign, 24 malignant) was performed in all cases (table). CT scans were obtained using a Somatom Emotion CT scanner (Siemens Healthineers; Malvern, Penn). For conventional CT, 5-mm slices were scanned at 110 kV and 120 mAs. The slice in which the mass lesion was widest in diameter was chosen for CTP. In patients with no lesions on routine enhanced CT, perfusion images were collected through clinically suspicious areas. At the selected level, 40 ml of contrast material at 4 ml/ sec was administered intravenously by an automatic injection device, and dynamic series slices were taken at 1-second intervals.
For dynamic investigation, 5-mm slices were scanned at 110 kV, 120 mAs, 1-second rotation, 22.5-second exposure time, and 8-second contrast delay time; an average of 40 slices was obtained per patient. The whole neck was completely scanned following a routine contrast-enhanced neck scanning protocol. Data were processed at the console using perfusion software for calculations. Levels of interest were centered around lesions, with selection of the largest enhancing area. For postprocessing, regions of interest (ROI) were placed in available arterial vessels (ipsilateral or contralateral), internal and external carotid arteries, which were usually the easiest to locate, and the internal jugular vein to generate contrast-enhanced curves at maximum intensity projection (MIP) sequences. The data were processed into maps for each arterial input, and capillary permeability (CP) surface product (in ml/100 g/min) and blood volume (BV) (in ml/100 g) were calculated.
Results
We located ROIs throughout the primary site (lesion or suspected lesion) and the muscles (base of the tongue and the mastication, paraspinous, and sternocleidomastoid muscles) at the same level (figures 1 to 3). BV values were higher in malignant masses than in benign lesions (142.9455 ml/100 g vs. 67.3208 ml/100 g, respectively), a difference that was statistically significant (p = 0.030). Although CP values were lower in malignant masses than in benign lesions (60.1273 ml/100 g/min vs. 111.8292 ml/100 g/min, respectively), this difference was not statistically significant (p = 0.206).
Discussion
Although CT and MRI examinations are important tools for evaluating head and neck pathologies, they do not allow functional evaluation. More recently, methods such as positron emission tomography, single-photon emission CT, and perfusion have been introduced to provide functional information. 1 Blood perfusion is a basic physiologic marker of metabolic activity and is thus useful for the diagnosis of abnormal tissues. CTP and MRI methods that measure perfusion assess average passing time and permeability. MRI methods are limited by motion artifacts and their inherent low spatial resolution. Furthermore, although the pharmacokinetics of gadolinium-based contrast agents are similar to those of ionic contrast media used for CTP, signal intensity does not depend linearly on gadolinium concentration, making absolute tumor perfusion measurements difficult. [2] [3] [4] [5] CTP detects blood flow in tissue, which depends not only on speed and volume, but also on capillary bed structure. In CTP, tissue perfusion is calculated in terms of attenuation changes during the first pass of the contrast material, using one of two mathematical methods. 6, 7 Changes in the concentration of contrast material, which correlates linearly with tissue attenuation, indicate perfusion.
Among the various algorithms and mathematical techniques for CT and tissue perfusion measurement, 8 the deconvolution method used here, pixel-based burst analysis, provides perfusion parameters from contiguous images in a single table position, is less sensitive to noise, requires less contrast material, and is more reliable as a measurement of perfusion than other methods. [5] [6] [7] 9 Currently, CTP is most commonly used in the clinic for the diagnosis of acute stroke and in oncology. 10 In the latter, CTP is used to characterize lung nodules; to detect occult liver metastases, brain gliomas and lymphomas, and head-neck cancers; and to evaluate responses to radiotherapy and chemotherapy. 1-3 Miles and Griffiths stressed the precise relationship between tumor angiogenesis, which is required for tumor growth, and contrast-enhanced CT. 9 Angiogenesis leads to increased perfusion, which causes higher BV and CP values. Other studies have confirmed that CTP can distinguish benign and malignant masses.
Gandhi et al, in a study of 14 patients with headneck squamous cell carcinoma (SCC), found that CTP parameters (BV, mean transit time [MTT], CP, and blood flow [BF]) are useful in differentiating these tumors from adjacent normal tissue. 10 Rumboldt et al demonstrated the utility of CTP after routine head and neck contrast-enhanced CT, except perhaps at the laryngeal level, and found that the method's results were reader-independent and reproducible and could distinguish between benign and malignant lesions, especially by means of MTT. 8 Similarly, Bisdas et al concluded that CTP allows for benign-malignant differentiation of parotid tumors from a study in 10 patients. 11 In a study of 41 patients with esophageal squamous cell tumors, Chen et al showed that BV values increase with tumor angiogenesis. 12 Liu et al used CTP in the axillary region in 25 patients with breast carcinoma, and found that CTP is a good means of assessing angiogenesis in lymph nodes. 13 Bisdas et al demonstrated that perfusion parameters differentiate among primary tumors, recurrent tumors, and normal tissues in 77 patients with oropharynx and oral cavity cancer. 14 Implementing CTP in head and neck primary and recurrent tumors, Faggioni et al found that the resulting functional information corresponds to tumor grading and treatment response. 15 Trojanowska et al determined that CTP increases staging accuracy, although not in malignant tumors, and in another study, found that it aids in the identification of tumor invasion in headneck squamous cell carcinoma. 16, 17 Faggioni et al also verified the efficiency of CTP in differentiating between SCC and normal tissue; BF and BV values are greater in cancerous than in normal tissue. 18 In agreement with the literature, we found that CP and BV values were significantly higher in tumors than in normal muscle. Furthermore, the difference in BV between malignant and benign tumors was statistically significant (p = 0.030; minimum of 26.90 ml/100 g vs. 5.30 ml/100 g). In contrast, Rumboldt et al remarked that BV values are not as useful in identifying neck masses as for brain tumors because of the high blood volume in salivary and thyroid glands. 8 This difference may be attributed to the exclusion of thyroid glands from our study. However, Bisdas et al found CTP useful for distinguishing between benign and malignant tumors in the salivary gland and attributed their divergent conclusions to different ROI volumes and partial volume effects. 11 A limitation of our study is high standard deviation values, likely resulting from microscopic necrosis Figure 2 . These photographs show regions of interest from patient 5, who presented with benign pleomorphic adenoma in the right parotid gland. A: A maximum intensity projection perfusion CT scan shows a mass in the right parotid gland. Region of interest 1 is in the lesion, and region of interest 2 is in the muscle. B: CTP functional map shows a relatively low blood volume of 43.6 ml/100 g in the lesion. The muscle has blood volume of 13.7 ml/100 g. The scale from blue to red corresponds with increasing volume. C: CTP map shows that the mass has relatively high permeability-207.7 ml/100g/min in region of interest 1 and 81.8 ml/100 g/min in region of interest 2. within lesions. Another is that hemorrhage caused by fine-needle aspiration before imaging might have artificially increased permeability, although we were careful to avoid necrosis and hemorrhage in drawing ROIs. Nonetheless, heterogeneity in mass lesions led to high standard deviations in perfusion parameters. The most important limitation is the high dose of ionizing radiation, but low-dose applications are being developed and are quite promising. Finally, using this approach in the head and neck is subject to motion artifacts caused by breathing and swallowing.
